<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1709">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05138913</url>
  </required_header>
  <id_info>
    <org_study_id>YLu</org_study_id>
    <nct_id>NCT05138913</nct_id>
  </id_info>
  <brief_title>Arthroscopic Treatment Combine With TXA for Elbow Stiffness</brief_title>
  <official_title>Prospective Randomized Controlled Study on Arthroscopic Treatment Combine With TXA for Elbow Stiffness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Jishuitan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Jishuitan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective randomized controlled study of different arthroscopic treatments&#xD;
      for elbow stiffness combined with tranexamic acid(TXA) injection. The patients with stiffness&#xD;
      were randomly divided into groups before the operation. After the arthroscopic operation was&#xD;
      completed, they were divided into a local TXA injection group and a control group (normal&#xD;
      saline) to perform additional operations for reduction of hemorrhage. In different time&#xD;
      periods, the quantitative and qualitative indicators including pain, functional score, range&#xD;
      of motion, level of Hemoglobin, the circumference of the limb 10cm above and below the elbow,&#xD;
      amount of hemorrhage, etc. were compared between groups at the same time period to evaluate&#xD;
      the difference in the effect of arthroscopic treatment combined with TXA on the treatment of&#xD;
      reduction of hemorrhage. Determine the effectiveness of TXA.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mayo Elbow Performance Score</measure>
    <time_frame>baseline-6 months postoperatively</time_frame>
    <description>A score used to evaluated the elbow function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analogue scale</measure>
    <time_frame>baseline-6 months postoperatively</time_frame>
    <description>A score used to evaluated the pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Circumference of upper extremity</measure>
    <time_frame>baseline-6 months postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of hemoglobin</measure>
    <time_frame>baseline-6 months postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>range of motion</measure>
    <time_frame>baseline-6 months postoperatively</time_frame>
    <description>flexion, extension, pronation and supination of elbow</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Tranexamic Acid</condition>
  <condition>Elbow Stiffness</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arthroscopic treatment with TXA injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Arthroscopic treatment with normal saline injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TXA</intervention_name>
    <description>After the arthroscopic operation was completed, a local TXA injection was performed</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>After the arthroscopic operation was completed, a local saline injection was performed</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Clinically diagnosed patients with elbow stiffness Young and middle-aged patients aged 18&#xD;
        to 60 with failed nonoperated treatment Voluntarily accept randomized controlled grouping,&#xD;
        cooperate with treatment and follow up patients No other comorbidities or medical diseases&#xD;
        affect the surgical patients -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Elderly people older than 60 years old and patients younger than 18 years old With severe&#xD;
        comorbidities or medical diseases affect the surgical patients&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi Lu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sports Medicine Service, Beijing Jishuitan hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shangzhe Li, M.D.</last_name>
    <phone>+86 13826162999</phone>
    <email>562744381@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Jishuitan hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shangzhe Li, M.D.</last_name>
      <phone>+86 13826162999</phone>
      <email>562744381@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 18, 2021</study_first_submitted>
  <study_first_submitted_qc>November 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2021</study_first_posted>
  <last_update_submitted>November 18, 2021</last_update_submitted>
  <last_update_submitted_qc>November 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Jishuitan Hospital</investigator_affiliation>
    <investigator_full_name>Yi Lu</investigator_full_name>
    <investigator_title>Director of Sports Medicine Service of Beijing Jishuitan hospital</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

